Plenge Robert M — SEC insider filings

SEC reporting owner CIK 1773367. 8 insider filings on record with FilingPulse; latest filed 2026-09-14.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2021-06-16 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BRISTOL MYERS SQUIBB CO (BMY)EVP, Chief Research Officer5—1 leg · 732 sh · $44,75451
Translate Bio, Inc. (TBIO)Director2——5
BIOMARIN PHARMACEUTICAL INC (BMRN)Director1——1

Insider filings — Plenge Robert M

FiledFormIssuerReported transactionsSource
2026-09-144BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 6,140 @ $0EDGAR
2026-03-124BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 1,107 @ $0 · Other (J): 124 @ $0 · Tax withholding (F): 436 @ $60.13 · Option exercise (M): 2,342 @ $0 · Other (J): 253 @ $0 · Tax withholding (F): 927 @ $60.13 · +8 moreEDGAR
2025-03-124BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 1,165 @ $0 · Other (J): 80 @ $0 · Tax withholding (F): 482 @ $63.11 · Option exercise (M): 1,107 @ $0 · Other (J): 193 @ $0 · Tax withholding (F): 406 @ $63.11 · +12 moreEDGAR
2024-03-124BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 994 @ $0 · Other (J): 157 @ $0 · Tax withholding (F): 246 @ $53.79 · Option exercise (M): 1,164 @ $0 · Other (J): 201 @ $0 · Tax withholding (F): 283 @ $53.79 · +10 moreEDGAR
2023-12-054BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 616 @ $0 · Tax withholding (F): 274 @ $50.10 · Option exercise (M): 616 (derivative) @ $0EDGAR
2023-08-074BRISTOL MYERS SQUIBB CO (BMY)Sale (S): 732 @ $61.14EDGAR
2021-09-144Translate Bio, Inc. (TBIO)Sale (S): 37,800 (derivative) @ $0 · Sale (S): 18,900 (derivative) @ $0 · Sale (S): 18,900 (derivative) @ $0 · Sale (S): 20,000 (derivative) @ $0EDGAR
2021-06-164Translate Bio, Inc. (TBIO)Grant/award (A): 20,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-06-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1773367 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs